RESUMO
Hyperglycemia in hospitalized patients, either with or without diabetes, is a common, serious, and costly healthcare problem. Evidence accumulated over 20 years has associated hyperglycemia with a significant increase in morbidity and mortality, both in surgical and medical patients. Based on this documented link between hyperglycemia and poor outcomes, clinical guidelines from professional organizations recommend the treatment of hospital hyperglycemia with a therapeutic goal of maintaining blood glucose (BG) levels less than 180 mg/dL. Insulin therapy remains a mainstay of glycemic management in the inpatient setting. The use of non-insulin antidiabetic drugs in the hospital setting is limited because little data are available regarding their safety and efficacy. However, information about the use of incretin-based therapy in inpatients has increased in the past 15 years. This review aims to summarize the different treatment strategies for hyperglycemia in hospitalized noncritical patients that are supported by observational studies or clinical trials with insulin and non-insulin drugs. In addition, we propose a protocol to help with the management of this important clinical problem.
Assuntos
Diabetes Mellitus , Hiperglicemia , Glicemia , Diabetes Mellitus/tratamento farmacológico , Humanos , Hiperglicemia/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Pacientes Internados , InsulinaRESUMO
Se presenta un estudio sobre ocho casos de micobacteriosis pulmonar tratados con un régimen combinado rifampicina-piracinamida-etambutol. Se hace un breve resumen sobre las características de la entidad. Se señalan los resultados obtenidos: mejoría clínica en todos los pacientes, conversión bacteriológica entre uno y tres meses; no recaídas durante el tratamiento, negatividad del esputo a los doce meses (tres cultivos) en los siete casos que llegaron a completar el esquema de un año; regresión radiológica en dos enfermos y evolución estacionaria en seis, pero en ninguno progresiva. Se concluye que este régimen terapéutico es útil y por tanto recomendable para los casos de micobacteriosis